Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Disentangling PTEN-cooperating tumor suppressor gene networks in cancer
Jorge de la Rosa1,2,3, Julia Weber4,5, Roland Rad1,4,5
1The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK.
Abstract:
We have recently performed a whole-body, genome-wide screen in mice using a single-copy inactivating transposon for the identification of Pten (phosphatase and tensin homolog)-cooperating tumor suppressor genes (TSGs). We identified known and putative TSGs in multiple cancer types and validated the functional and clinical relevance of several promising candidates for human prostate cancer.
Insights
Researchers identified new tumor suppressor genes cooperating with PTEN (phosphatase and tensin homolog) using a genome-wide screen in mice. Several promising candidates were validated for their relevance in human prostate cancer.
Area of Science:
- Genetics
- Cancer Biology
- Genomics
Background:
- PTEN (phosphatase and tensin homolog) is a critical tumor suppressor gene.
- Loss of PTEN function is common in many human cancers, particularly prostate cancer.
- Identifying cooperating tumor suppressor genes (TSGs) is crucial for understanding cancer development and finding new therapeutic targets.
Purpose of the Study:
- To perform a genome-wide screen to identify novel tumor suppressor genes (TSGs) that cooperate with PTEN.
- To discover genes involved in PTEN-deficient cancers.
- To validate the functional and clinical relevance of identified TSGs in human prostate cancer.
Main Methods:
- A whole-body, genome-wide screen was conducted in mice.
- A single-copy inactivating transposon system was utilized for gene inactivation.
- Functional and clinical relevance of candidate TSGs were assessed for human prostate cancer.
Main Results:
- The screen identified known and putative tumor suppressor genes (TSGs).
- These genes cooperate with PTEN across multiple cancer types.
- Several promising TSG candidates demonstrated functional and clinical relevance for human prostate cancer.
Conclusions:
- A comprehensive screen successfully identified novel PTEN-cooperating TSGs.
- The findings highlight the importance of these TSGs in various cancers.
- Validated candidates offer potential for future therapeutic strategies in prostate cancer treatment.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

